AOD9604 and Oral Bioavailability Research Pharmacokinetic profiling in pigs confirmed that AOD9604 is orally bioavailable, with intact peptide and its principal N-terminal truncation degradants (2aa and 3aa fragments) detected in plasma following oral dosing
For a 5 mg vial, adding 2 mL of bacteriostatic water gives a 2,500 mcg/mL concentration where a 500 mcg dose equals 20 units on a U-100 insulin syringe
Key areas of research interest include the following
Targeted fat metabolism and energy support Physician-prescribed lipotropic MIC + B12 injections to support fat metabolism, liver health, and energy
PGC-1 and mitochondrial biogenesis ERR works in partnership with PGC-1, the master coactivator of mitochondrial biogenesis
The "best" peptide for a marathon runner recovering from a tendon injury is different from the best one for someone focused on weight loss, which is different again from someone whose main goal is better sleep and graceful aging